Recce Pharmaceuticals (R9Q.STU) Q1 2026 Earnings

27FebConfirmed
Q1 2026
-0.03
0.3
0.63
0.97

Details

Expected EPS
N/A
Actual EPS
-0.0323569475775
Surprise EPS
-0.03
Surprise Percent
+∞%

Description

Recce Pharmaceuticals (R9Q.STU) has reported earnings of -0.0323569475775 per share for Q1 2026.

0 Comments

Share your thoughts